Optum Insight (Clinformatics DataMart) Data Acquisition

Optum Insight（Clinformatics DataMart）数据采集

• 批准号: 10495329
• 负责人: CLIFF WHITE
• 金额: $ 25万
• 依托单位: QUALITYMETRIC, INC.
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-27 至 2022-09-26
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10495329
• 关键词: Blinded; Characteristics; Complement; Contracts; Cost Savings; Data; Data Mart; Data Sources; Disease; Electronic Health Record; Enrollment; Epidemiology; Health; Insurance; Laboratories; Link; Medicaid; Medical; Medicare; Medicare Part C; Minority Groups; National Health and Nutrition Examination Survey; National Institute of Diabetes and Digestive and Kidney Diseases; Patients; Population; Privatization; Prognosis; Recording of previous events; Records; Source; Surveys; Test Result; United States National Center for Health Statistics; data acquisition; insight; interest; longitudinal analysis; member; patient health information; patient population; patient privacy; pharmacy benefit; statistics

NIDDK epidemiology contracts provide a compendium of vital information on the burden, characteristics and prognosis of diseases of interest to the various divisions. In order to provide meaningful information to stakeholders, a variety of data sources are required. These include various NCHS sources including NHANES, a nationally representative survey conducted by NCHS; CMS data obtained directly from CMS, which demographically represents an older, more likely retired, and disproportionately minority population. More recently, private insurance data, such as Optum Insight, which provides information on a younger, more likely employed population, and thus complementary and providing a more fully representative population than CMS data alone, has been obtained. In the most recent iteration of the contact last year, various members of the acquisition planning team recommended acquisition of Optum data be shared among various divisions, and potentially even other IC’s, as an efficient and cost saving strategy. Optum Insight is a company of United Health Group. It provides an integrated enrollment, medical and prescription claims data augmented with laboratory test results data. It only members with both medical and pharmacy benefits. Includes UHC fully insured, Medicaid, and legacy Medicare Choice membership and claims. Blinded data to protect patient privacy, yet supports patient-linked longitudinal analysis. CDM Statistics May 2000 through June 2012 (10+ years of history) 61 million membership records 50 million unique members Roughly 14 million covered lives per year

NIDDK流行病学合同提供了有关各个部门感兴趣的疾病的烧伤，特征和预后的重要信息。为了向利益相关者提供有意义的信息，需要多种数据源。这些包括NHANES在内的各种NCH来源，NHANES是NCHS进行的全国代表性调查； CMS直接从CMS获得的CMS数据，该数据在人口统计学上代表了较旧的，更可能退休且少数群体不成比例的数据。最近，已经获得了私人保险数据，例如Optum Insight，该数据提供了有关年轻，更可能受雇的人群的信息，因此已经获得了与CMS数据相比，已完成并提供更具代表性的人群。在去年联系的最新联系中，收购计划团队的各个成员建议在各个部门（甚至可能是其他IC）之间共享optum数据，以此作为一种有效的成本节省策略。 Optum Insight是联合卫生集团的一家公司。它提供了通过实验室测试结果数据增强的综合注册，医疗和处方索赔数据。它只有具有医疗和药房福利的成员。包括UHC完全保险，医疗补助和传统医疗保险选择会员资格和主张。盲目的数据保护患者隐私，但支持患者关联的纵向分析。 CDM统计 2000年5月至2012年6月（历史十多年） 6100万会员记录 5000万独特成员 每年约有1400万覆盖生命